Forward Science (ROCO:7530) EBIT: NT$-80.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7530 Forward Science Corp ROCO:7530
38 GF Score
Price NT$38.55
GF Value NT$14.15
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Forward Science EBIT?

Forward Science ROCO:7530 +1.05% 38 EBIT is NT$-80.9 Mil as of Dec. 2025. GuruFocus rates ROCO:7530 with a GF Score™ of 38/100 and a GF Value™ of NT$14.15 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Forward Science's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was NT$-41.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-80.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Forward Science's annualized ROC % for the quarter that ended in Dec. 2025 was -14.00%. Forward Science's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -15.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Forward Science's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -3.98%.

Forward Science  (ROCO:7530) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Forward Science's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-83.808 * ( 1 - 0% )/( (608.559 + 588.882)/ 2 )
=-83.808/598.7205
=-14.00 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=672.312 - 36.881 - ( 26.872 - max(0, 190.084 - 457.622+26.872))
=608.559

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=687.152 - 51.945 - ( 46.325 - max(0, 263.734 - 486.711+46.325))
=588.882

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Forward Science's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-83.794/( ( (198.12 + max(329.583, 0)) + (186.927 + max(348.855, 0)) )/ 2 )
=-83.794/( ( 527.703 + 535.782 )/ 2 )
=-83.794/531.7425
=-15.76 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(26.218 + 340.574 + 9.12) - (36.881 + 0 + 9.448)
=329.583

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(51.779 + 347.047 + 10.836) - (51.945 + 0 + 8.862)
=348.855

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Forward Science's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-80.919/2033.639
=-3.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forward Science EBIT Related Terms

Forward Science EBIT Historical Data

* Premium members only.

The historical data trend for Forward Science's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forward Science EBIT Chart

Forward Science Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 15.87 -66.26 -19.24 -55.22 -80.92

Forward Science Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.87 -18.24 -36.98 -39.02 -41.90

ROCO:7530 vs GEV, ETN, PH: EBIT Comparison

For the Specialty Industrial Machinery subindustry, Forward Science's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forward Science EV-to-EBIT vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Forward Science's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Forward Science's EV-to-EBIT falls into.


ROCO:7530
38GF Score
Forward Science Corp ROCO:7530
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forward Science EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-80.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of NT$-80.9 Mil mean?
Forward Science (ROCO:7530) has a EBIT of NT$-80.9 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Forward Science.
Is Forward Science's EBIT too high?
Forward Science's current EBIT is NT$-80.9 Mil. Overall, Forward Science has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Forward Science's EBIT compare to GEV and ETN?
Forward Science's EBIT of NT$-80.9 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Industrial Products company?
A good EBIT depends on the Industrial Products industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Forward Science. Forward Science's current EBIT is NT$-80.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forward Science stock overvalued right now?
Based on GuruFocus' analysis, Forward Science (ROCO:7530) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.15, compared to a current price of NT$38.55 — trading 172.4% above its estimated fair value. The current EBIT is NT$-80.9 Mil. Forward Science's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Forward Science (ROCO:7530), the current EBIT is NT$-80.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Forward Science (ROCO:7530) Overvalued in 2026?

Based on GuruFocus' analysis, Forward Science stock appears to be overvalued. The current stock price of NT$38.55 is trading 172.4% above its estimated GF Value™ of NT$14.15. GuruFocus considers Forward Science to be Significantly Overvalued.

Key valuation signals for ROCO:7530:

  • EBIT: NT$-80.9 Mil
  • GF Value™: NT$14.15 vs. price of NT$38.55 (172.4% above fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the ROCO:7530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Forward Science Business Description

Address 232 Youyi Road, Gongyi Village, Zhunan Township, Jhunan, TWN, 350
Forward Science Corp is engaged in the manufacturing and maintenance of vacuum pumps. It is also involved in precision parts manufacturing that includes Stainless Processing, Aluminum Processing, Casting Processing, and Metal Finishing among others. Geographically, the company generates the majority of its revenue from Taiwan.
38GF Score

Get the complete analysis for ROCO:7530

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.55
Price
NT$14.15
GF Value